Clinical Trial Details

FT522-101: A Phase 1 Study of FT522 in Combination with Rituximab in Participants with Relapsed/Refractory BCell Lymphoma

Categories (click each to see list of all clinical trials associated with that category): Cellular Therapy Support Service - Other CAR (ONC), Lymphoma/CLL (ONC)

Current Status: Open

Phase: I (Cancer Control)

Principal Investigator: Lunning, Matthew